BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 04/05/2016

FDA Announces Draft Guidance for Direct-Acting Antiviral Drugs for Chronic Hepatitis C Treatment

The FDA is releasing a revised draft guidance to help pharmaceutical companies develop effective treatments for chronic hepatitis C using direct-acting antiviral drugs.

Source: Federal Register — Food and Drug AdministrationOpen original release →